BICYCLIC ANILIDE HETEROCYCLIC CGRP RECEPTOR ANTAGONISTS
    23.
    发明申请
    BICYCLIC ANILIDE HETEROCYCLIC CGRP RECEPTOR ANTAGONISTS 审中-公开
    双相抗体杂交CGRP受体拮抗剂

    公开(公告)号:WO2008130512A1

    公开(公告)日:2008-10-30

    申请号:PCT/US2008/004694

    申请日:2008-04-11

    CPC classification number: C07D471/20 C07D519/00

    Abstract: Compounds of formula I: I (wherein variables A1, A2, B, m, n, J, R4, G1, G2, G3 and Y are as described herein) which are antagonists of CGRP receptors and which are useful in the treatment or prevention of diseases in which the CGRP is involved, such as migraine. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.

    Abstract translation: 式I:I(其中变量A1,A2,B,m,n,J,R4,G1,G2,G3和Y如本文所述)是CGRP受体的拮抗剂,其可用于治疗或预防 涉及CGRP的疾病,如偏头痛。 本发明还涉及包含这些化合物的药物组合物以及这些化合物和组合物在预防或治疗涉及CGRP的疾病中的用途。

    MONOCYCLIC ANILIDE SPIROLACTAM CGRP RECEPTOR ANTAGONISTS
    24.
    发明申请
    MONOCYCLIC ANILIDE SPIROLACTAM CGRP RECEPTOR ANTAGONISTS 审中-公开
    单环尼古丁螺旋藻CGRP受体拮抗剂

    公开(公告)号:WO2008112159A3

    公开(公告)日:2008-10-30

    申请号:PCT/US2008003078

    申请日:2008-03-07

    CPC classification number: C07D471/20 C07D403/12 C07D471/10 C07D519/00

    Abstract: The present invention is directed to compounds of Formula I: I (where variables A 1 , A 2 , B, J, K, m, n, R 4 , R 5a , R 5b and R 5c are as defined herein) useful as antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which the CGRP is involved, such as headache, migraine and cluster headache. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.

    Abstract translation: 本发明涉及式I化合物:其中变量A 1,A 2,B,J,K,m,n,R 4 R 5,R 5和R 5c如本文所定义)可用作CGRP受体的拮抗剂并可用于治疗 或预防涉及CGRP的疾病,如头痛,偏头痛和丛集性头痛。 本发明还涉及包含这些化合物的药物组合物以及这些化合物和组合物在预防或治疗涉及CGRP的此类疾病中的用途。

    MONOCYCLIC ANILIDE SPIROLACTAM CGRP RECEPTOR ANTAGONISTS
    25.
    发明申请
    MONOCYCLIC ANILIDE SPIROLACTAM CGRP RECEPTOR ANTAGONISTS 审中-公开
    单克隆抗炎螺旋体CGRP受体拮抗剂

    公开(公告)号:WO2008112159A2

    公开(公告)日:2008-09-18

    申请号:PCT/US2008/003078

    申请日:2008-03-07

    CPC classification number: C07D471/20 C07D403/12 C07D471/10 C07D519/00

    Abstract: The present invention is directed to compounds of Formula I: I (where variables A 1 , A 2 , B, J, K, m, n, R 4 , R 5a , R 5b and R 5c are as defined herein) useful as antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which the CGRP is involved, such as headache, migraine and cluster headache. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.

    Abstract translation: 本发明涉及式I化合物:其中变量A 1,A 2,B,J,K,m,n,R 4 R 5c,R 5b和R 5c如本文所定义)可用作CGRP受体的拮抗剂并且可用于治疗 或预防CGRP所涉及的疾病,如头痛,偏头痛和丛集性头痛。 本发明还涉及包含这些化合物的药物组合物以及这些化合物和组合物在预防或治疗涉及CGRP的疾病中的用途。

    BICYCLIC SPIROHYDANTOIN CGRP RECEPTOR ANTAGONISTS
    27.
    发明申请
    BICYCLIC SPIROHYDANTOIN CGRP RECEPTOR ANTAGONISTS 审中-公开
    双相SPIROHYDANTOIN CGRP受体拮抗剂

    公开(公告)号:WO2007061695A3

    公开(公告)日:2007-12-06

    申请号:PCT/US2006044194

    申请日:2006-11-14

    CPC classification number: C07D487/10 C07D471/10

    Abstract: Compounds of formula I: (wherein variables A 1 , A 2 , A 3 , A 4 , A 5 , A 6 , A 7 , B, E 1 , E 2 , E 3 , E 4 , E 5 , G 1 , G 2 and R 6 are as described herein) which are antagonists of CGRP receptors and which are useful in the treatment or prevention of diseases in which the CGRP is involved, such as migraine. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.

    Abstract translation: 式I化合物:(其中变量A 1,A 2,A 3,A 4,A 4, 第5类,第6类,第7类,第B类,第1类,第2类, E 3,E 4,E 5,G 1,G 2和 R 6如本文所述),其是CGRP受体的拮抗剂,其可用于治疗或预防涉及CGRP的疾病,例如偏头痛。 本发明还涉及包含这些化合物的药物组合物以及这些化合物和组合物在预防或治疗涉及CGRP的疾病中的用途。

Patent Agency Ranking